Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olli Lohi

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Targeted Oncology|September 8, 2025
Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric PatientsTianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann, et al.
Occupational and Environmental Medicine|July 31, 2019
Parental occupational exposure to low-frequency magnetic fields and risk of leukaemia in the offspring: findings from the Childhood Leukaemia International Consortium (CLIC)Madar Talibov, Ann Olsson, Helen Bailey, et al.
Leukemia|October 28, 2025
Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 studyAtte Nikkilä, Olli Lohi, Jonas Abrahamsson, et al.
Life Science Alliance|March 18, 2024
Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumorsMeeri Pekkarinen, Kristiina Nordfors, Joonas Uusi-Mäkelä, et al.
Leukemia|February 13, 2021
Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li-Fraumeni syndromeGreta Winter, Renate Kirschner-Schwabe, Stefanie Groeneveld-Krentz, et al.
Leukemia|July 9, 2025
Genomic determinants of therapy response in ETV6::RUNX1 leukemiaLaura Oksa, Sanni Moisio, Khurram Maqbool, et al.
Frontiers in Oncology|May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care TherapySebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.
Cancer Discovery|March 3, 2018
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia DevelopmentCharles E de Bock, Sofie Demeyer, Sandrine Degryse, et al.
Hemasphere|February 4, 2025
Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressureMira Kusterer, Mari Lahnalampi, Minna Voutilainen, et al.
Acta Neuropathologica Communications|June 27, 2025
Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohortTom T Fischer, Kendra K Maaß, Pitithat Puranachot, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Targeted Oncology|September 8, 2025
Published Population Pharmacokinetic Models of Imatinib Perform Poorly on TDM Data from Pediatric PatientsTianwu Yang, Anna Sofie Buhl Rasmussen, Allan Weimann, et al.
Occupational and Environmental Medicine|July 31, 2019
Parental occupational exposure to low-frequency magnetic fields and risk of leukaemia in the offspring: findings from the Childhood Leukaemia International Consortium (CLIC)Madar Talibov, Ann Olsson, Helen Bailey, et al.
Leukemia|October 28, 2025
Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 studyAtte Nikkilä, Olli Lohi, Jonas Abrahamsson, et al.
Life Science Alliance|March 18, 2024
Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumorsMeeri Pekkarinen, Kristiina Nordfors, Joonas Uusi-Mäkelä, et al.
Leukemia|February 13, 2021
Clinical and genetic characteristics of children with acute lymphoblastic leukemia and Li-Fraumeni syndromeGreta Winter, Renate Kirschner-Schwabe, Stefanie Groeneveld-Krentz, et al.
Leukemia|July 9, 2025
Genomic determinants of therapy response in ETV6::RUNX1 leukemiaLaura Oksa, Sanni Moisio, Khurram Maqbool, et al.
Frontiers in Oncology|May 27, 2022
No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care TherapySebastian Johannes Schober, Erika Hallmen, Florian Reßle, et al.
Cancer Discovery|March 3, 2018
HOXA9 Cooperates with Activated JAK/STAT Signaling to Drive Leukemia DevelopmentCharles E de Bock, Sofie Demeyer, Sandrine Degryse, et al.
Hemasphere|February 4, 2025
Dynamic evolution of TCF3-PBX1 leukemias at the single-cell level under chemotherapy pressureMira Kusterer, Mari Lahnalampi, Minna Voutilainen, et al.
Acta Neuropathologica Communications|June 27, 2025
Ultra-low-input cell-free DNA sequencing for tumor detection and characterization in a real-world pediatric brain tumor cohortTom T Fischer, Kendra K Maaß, Pitithat Puranachot, et al.
Pageof 11